{"brief_title": "Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)", "brief_summary": "The purpose of this study is to assess the cholesterol lowering safety and effectiveness of two investigational drugs in patients with mixed hyperlipidemia (high cholesterol and high triglycerides).", "detailed_description": "The duration of treatment is 48 weeks.", "condition": "Hypertriglyceridemia", "intervention_type": "Drug", "intervention_name": "Comparator: fenofibrate monotherapy", "criteria": "Inclusion Criteria: - High cholesterol and high triglycerides Exclusion Criteria: - Patient has a condition which, in the opinion of the investigator, might pose a risk to the patient, interfere with participation in the study, or does not meet the additional criteria as required by the study", "gender": "All", "minimum_age": "18 Years", "maximum_age": "75 Years", "healthy_volunteers": "No", "id": "NCT00092573.xml"}